Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

3,911 studies for “multiple sclerosis”

High-Intensity Interval Training for Walking and Function Across Different Multiple Sclerosis Disability LevelsRecruiting
NCT07771868NAUpdated Sep 10, 2026
Sponsor: Hacettepe University
MULTIPL SCLEROSİS
Turkey (Türkiye)
Effect of High Intensity Training on Motor and Cognitive FunctionsCompleted
NCT06219304NAUpdated Sep 10, 2026
Sponsor: Fondazione Don Carlo Gnocchi ETS
Multiple Sclerosis
Italy
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisRecruiting
NCT07299019Phase 3Updated Sep 10, 2026
Sponsor: Zenas BioPharma (USA), LLC
Secondary Progressive Multiple Sclerosis
United States, Croatia, Czechia, Estonia, Italy +4 more
Role of Genetic Factors in the Development of Lung DiseaseRecruiting
NCT00001532N/AUpdated Sep 10, 2026
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Cystic Fibrosis · Pulmonary Fibrosis · Tuberous Sclerosis · Asthma
United States
Effects of Virtual Reality on Sleep Quality and Mental Well-beingCompleted
NCT06074419NAUpdated Sep 10, 2026
Sponsor: Ataturk University
Nursing Caries
Turkey (Türkiye)
A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)Recruiting
NCT07161258Phase 2Updated Sep 10, 2026
Sponsor: Hoffmann-La Roche
Relapsing Multiple Sclerosis
Argentina, Brazil, Mexico, Poland, Portugal +2 more
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple SclerosisRecruiting
NCT06408259Phase 3Updated Sep 10, 2026
Sponsor: Bristol-Myers Squibb
Multiple Sclerosis, Relapsing-Remitting
United States, Australia, Italy, Mexico, Poland +6 more
A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisRecruiting
NCT07067463Phase 3Updated Sep 10, 2026
Sponsor: Zenas BioPharma (USA), LLC
Multiple Sclerosis (MS) Primary Progressive
United States, Bulgaria, Croatia, Czechia, Estonia +11 more
Digital App for Speech & Health MonitoringRecruiting
NCT06450418N/AUpdated Sep 10, 2026
Sponsor: University of Edinburgh
Dementia · Motor Neuron Disease · Multiple Sclerosis · Parkinson Disease
United Kingdom
The Mediating Role of Balance in the Relationship Between Fatigue and Fear of Falling in Individuals With Multiple SclerosisCompleted
NCT07680049N/AUpdated Sep 10, 2026
Sponsor: Uskudar University
Multiple Sclerosis
Turkey (Türkiye)
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability StudyRecruiting
NCT06649955NAUpdated Sep 10, 2026
Sponsor: PathMaker Neurosystems Inc.
ALS - Amyotrophic Lateral Sclerosis
United States
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune DiseaseNot Yet Recruiting
NCT07804004Phase 1, Phase 2Updated Sep 9, 2026
Sponsor: CRISPR Therapeutics
Progressive Multiple Sclerosis (PMS) · Neuromyelitis Optica · Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease · Autoimmune Encephalitis
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune DisordersRecruiting
NCT06680037Phase 1Updated Sep 9, 2026
Sponsor: TG Therapeutics, Inc.
B-cell Mediated Autoimmune Disorders
United States
Emerging Indications for Hyperbaric Oxygen TreatmentNot Yet Recruiting
NCT07240649Phase 4Updated Sep 9, 2026
Sponsor: Jay C. Buckey Jr.
Post-COVID-19 Condition · Ulcerative Colitis · Crohn Disease · Calciphylaxis
Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and NeuroinflammationActive Not Recruiting
NCT06551649NAUpdated Sep 9, 2026
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Amyotrophic Lateral Sclerosis · Multiple Sclerosis
Italy
Driving Performance in Parkinson's Disease and Multiple Sclerosis Using a Driving SimulatorNot Yet Recruiting
NCT07809828N/AUpdated Sep 9, 2026
Sponsor: University Hospital Olomouc
Parkinson · Multiple Sclerosis
VIGIP-SEP2: Training of Patients by Nurses on ADR Reporting by RRMS Patient Via an AppCompleted
NCT04116424NAUpdated Sep 9, 2026
Sponsor: University Hospital, Caen
Multiple Sclerosis
France
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis SpasticityRecruiting
NCT06782490Phase 2Updated Sep 9, 2026
Sponsor: Celgene
Multiple Sclerosis Spasticity
United States, Australia, Canada, Czechia, Germany +2 more
Cannabis (THC vs. CBD) in Multiple SclerosisRecruiting
NCT06261489Phase 2Updated Sep 9, 2026
Sponsor: University of Calgary
Multiple Sclerosis
Canada
Clinical Pilates for Balance and Function in Multiple SclerosisCompleted
NCT07800039NAUpdated Sep 9, 2026
Sponsor: University of Patras
Multiple Sclerosis
Greece
Exploring the Utility of [18F]3F4AP for Demyelination ImagingRecruiting
NCT06999434Phase 1Updated Sep 9, 2026
Sponsor: Yale University
Demyelinating Disorders · MCI · Alzheimer's Disease (AD) · MS (Multiple Sclerosis)
United States
Clinical Investigation to Validate the Safety and Performance of Integrating Functional Electrical Stimulation Into the ABLE ExoskeletonCompleted
NCT07550699NAUpdated Sep 8, 2026
Sponsor: ABLE Human Motion S.L.
Acquired Brain Injury (Including Stroke) · Spinal Cord Injury · Multiple Sclerosis
Austria
Early Detection of Selected Neuropathologies in Motor Vehicle DriversRecruiting
NCT07360886N/AUpdated Sep 8, 2026
Sponsor: University Hospital Olomouc
Multiple Sclerosis · Parkinson Disease
Czechia
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 TherapyRecruiting
NCT07609719Phase 4Updated Sep 8, 2026
Sponsor: Genentech, Inc.
Multiple Sclerosis
United States, Puerto Rico
ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple SclerosisActive Not Recruiting
NCT04695080Phase 2, Phase 3Updated Sep 8, 2026
Sponsor: Queen Mary University of London
Advanced Multiple Sclerosis · Progressive Multiple Sclerosis
United Kingdom

3,911 studies found